Saturday, June 9

Meet-the-Expert | Clinical Trial Update | Science in Progress | Simultaneous Sessions I | Hematolgy-in-Focus Session | Clinical Trial Update | Simultaneous Sessions II | Lunch Debate | EHA / ASH Joint Symposium on Stem Cell Banking | EHA Business Meeting | Presidential Symposium | Plenary Session I | Poster Session II

PRESIDENTIAL SYMPOSIUM

15.00 - 16.30 hours, Room: Mozart I

PRESIDENTIAL SYMPOSIUM – 6 BEST ABSTRACTS

Chairs: E. Hellström-Lindberg (Karolinska Institutet, Stockholm, Sweden)
H. Ludwig (Wilhelminenspital, Vienna, Austria)

15:00 - 15:15

0441 PRIMARY ALLOGENEIC STEM CELL TRANSPLANTATION VERSUS BEST AVAILABLE DRUG TREATMENT IN CHRONIC MYELOID LEUKEMIA

R. Hehlmann, T. Lahaye, M. Pfirrmann, A. Hochhaus, M.C. Müller, A. Reiter, J. Hasford, H.J. Kolb, H. Heimpel, D.K. Hossfeld, A. Gratwohl, Germany And the German CML Study Group (Medizinische Fakultät Mannheim, Mannheim, Germany)

15:15 - 15:30

0442 DUPLICATION OF THE MYB ONCOGENE IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

I. Lahortiga, K. De Keersmaecker, P. Van Vlierberghe, C. Graux, B. Cauwelier, F. Lambert, N. Mentens, H.B. Beverloo, R. Pieters, F. Speleman, M.D. Odero, M. Bauters, G. Froyen, P. Marynen, P. Vandenberghe, I. Wlodarska, J. Meijerink, J. Cools (KULeuven, Leuven, Belgium)

15:30 - 15:45

0443 THE JAK2 V617F MUTATION IS PRESENT IN A MINORITY OF HUMAN HEMATOPOIETIC STEM CELLS FROM PATIENTS WITH MYELOPROLIFERATIVE DISORDERS AND DOES NOT MODIFY THEIR SELF-RENEWAL PROPERTIES

C. James, F. Mazurier, R. Chaligne, I . Lamrissi-Garcia, S. Dupont, S. Giraudier, F. Delhommeau, E. Lippert, F.X. Mahon, J.M. Pasquet, H. De Verneuil, W. Vainchenker (INSERM U876, Bordeaux, France)

15:45 - 16:00

0444 A MOLECULAR CLASSIFICATION OF LEUKAEMIA REVEALS MDS AS A DISEASE CONTINUUM WITH NON-LEUKAEMIA AND AML SUB GROUPS

K.I. Mills, A.F. Gilkes, J. Hernandez, W.-K. Hofmann, A. Kohlmann, M. Williams, L. Wieczorek, T. Haferlach (Cardiff University, Cardiff United Kingdom)

16:00 - 16:15

0445 IDENTIFICATION OF THE CHROMATIN-REMODELING PROTEIN SATB1 AS A DEVELOPMENT-DEPENDENT LONG-RANGE TRANSCRIPTIONAL REGULATOR OF THE PU.1 GENE

U. Steidl, C. Steidl, A. Ebralidze, H.J. Han, B. Will, F. Rosenbauer, S. Kobayashi, K.B. O'Brien, D. Haase, T. Kohwi-Shigematsu, D.G. Tenen (Harvard Institute of Medicine, Boston, USA)\

16:15 - 16:30

0446 THALIDOMIDE-DEXAMETHASONE VERSUS MELPHALANPREDNISOLONE AS FIRST LINE TREATMENT IN ELDERLY PATIENTS WITH MULTIPLE MYELOMA: SECOND INTERIM ANALYSIS

H. Ludwig, E. Tóthová, J. Drach, R. Hajek, B. Labar, M. Egyed, I. Spicka, H. Gisslinger, R. Greil, A. Hinke, N. Zojer, I. Kuhn, W. Linkesch, M. Fridrik, M. Mistrik, B. Jaksic, R. Kusec (Wilhelminenspital, Vienna, Austria)

---

[ Top of page ]